A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
about
Targeted therapies in sarcomas: challenging the challengeEvasion mechanisms to Igf1r inhibition in rhabdomyosarcomaInvestigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitorsIGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis.Effect of inhibition of the ubiquitin-proteasome system and Hsp90 on growth and survival of rhabdomyosarcoma cells in vitro.Activity of the heat shock protein 90 inhibitor ganetespib in melanomaTargeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.Heat shock response and insulin-associated neurodegeneration.The clinical use of biomarkers as prognostic factors in Ewing sarcoma.The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedinHsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma.Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d.Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.Past, present and future of therapies in pediatric sarcomas.Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.Targeted therapies for bone sarcomas.Targeted polytherapy in small cell sarcoma and its association with doxorubicin.HSP27 expression levels are associated with the sensitivity of hepatocellular carcinoma cells to 17-allylamino-17-demethoxygeldanamycin.Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer activity by down-regulation of the IGF-1R/Akt pathway in breast cancer cells.Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives.Bone sarcomas: from biology to targeted therapies.Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance.Immunohistochemical analysis of expressions of RB1, CDK4, HSP90, cPLA2G4A, and CHMP2B is helpful in distinction between myxofibrosarcoma and myxoid liposarcoma.
P2860
Q21285014-7B814779-35EF-4182-9974-FC9D78E2156DQ30411769-564555CE-9B0E-4DAD-B6BD-0AF4B81E9CF8Q33559559-9A752CBB-0CAD-41D2-9E25-1BFBFD5FBEA8Q33808340-2CCDB1F9-9F1A-4919-8E9B-7A3036BF5DD7Q33911391-1C34E1D7-55F5-4F16-A2B9-5CC451775520Q34301113-4F801B1A-F03D-4F0D-9CD4-89AD64CA6C4DQ34589866-A3DD9C50-34BF-4D52-B9E4-5BB5015FD283Q35013284-10E19A75-ABFE-415E-A429-523CA7C03476Q35429717-5F53C616-B62E-43E6-976E-99B999CC3E74Q35555492-506FD00D-EFBA-41F2-863E-FEDB4FF7687CQ35870561-DEBD0A46-89C3-4CF2-98C4-DBAE07EDFFE5Q35957979-16BE18CB-C00B-421E-9143-E7CAA8BF2571Q36326279-E56A3DE7-7ABA-4C10-B304-D8B47791F035Q37081037-55AEDDF1-F6BF-4B39-AD22-6E697C61A4AAQ37222280-5C7B198F-F395-4B6E-9487-5617F93A5B5BQ37421580-5BA168EC-5FE8-431F-AE7F-58817142648AQ37424554-93845201-0E3C-4E35-844B-57879C601EB0Q37695872-C9393468-0DD5-432B-A6DB-FCE14612F080Q37725915-AC05EEFD-8AD7-43D6-9F88-22DADA219A95Q37813152-BAC2D468-B7D6-4DD1-9E3E-ACD89031DE43Q37975246-0D2AA686-2C35-4EAE-AEFD-42CA03B97987Q38178277-A961EEFB-C5B4-4BF2-BCEA-ED4EDC65CC5CQ38977714-6D026994-729F-4B70-A0EE-B3038CA45E8FQ39455533-6AC87C97-A96D-46EB-B2F3-1065DD59AF78Q39508422-2BD6096E-CF32-4910-BCA7-CDA4BB5DA586Q39767891-67FCA4FD-3178-48C2-BE35-0AEE1FBF3A6CQ41923624-7083614D-3F60-4E6A-9C41-C2A92F77B7A7Q42579657-D85E4114-F504-4BDD-8EDA-756FEA3CB92BQ54355782-35B22C6E-4F4E-4C84-AC76-C434EFD2A6F7
P2860
A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@ast
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@en
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@nl
type
label
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@ast
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@en
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@nl
prefLabel
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@ast
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@en
A pivotal role for heat shock ...... t: in vitro and in vivo study.
@nl
P2093
P1433
P1476
A pivotal role for heat shock ...... nt: in vitro and in vivo study
@en
P2093
Ana Pastora Otero
Ana Sofia Martins
Carlos Mackintosh
Christopher Poremba
Daniel Osuna
David Herrero
Gemma Caballero
José Luis Ordoñez
Juan Madoz-Gúrpide
Victoria Sevillano
P304
P356
10.1158/0008-5472.CAN-07-3074
P407
P577
2008-08-01T00:00:00Z